EUVIMEDEUVIMED entdecken
Open Access

Swiss trial of decompressive craniectomy versus best medical treatment of spontaneous supratentorial intracerebral haemorrhage (SWITCH): an international, multicentre, randomised-controlled, two-arm, assessor-blinded trial

Urs Fischer iD, Christian Fung, Seraina Beyeler, Lukas Bütikofer, Werner Z'Graggen iD, Florian Ringel, Jan Gralla, Karl Schaller, Nikolaus Plesnila, Daniel Strbian iD, Marcel Arnold, Werner Hacke und 10 weitere

European Stroke Journal · 2024

DOI: 10.1177/23969873241231047 ↗

Kurz gefasst

Fachartikel in der Zeitschrift European Stroke Journal, 2024. Verfasst von Urs Fischer und 21 weiteren Autor:innen. Beteiligte Einrichtung: Department of Neurology, University Hospital and University of Bern, Bern, Switzerland. Hauptthemen laut MEDLINE: Cerebral Hemorrhage, Decompressive Craniectomy. Die Arbeit wurde bisher 8-mal zitiert (Crossref) und nennt 23 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar. Gefördert von: Schweizerischer Nationalfonds zur Förderung der Wissenschaftlichen Forschung, Boehringer Ingelheim, the Inselspital Stiftung.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Rationale

Decompressive craniectomy (DC) is beneficial in people with malignant middle cerebral artery infarction. Whether DC improves outcome in spontaneous intracerebral haemorrhage (ICH) is unknown.

Aim

To determine whether DC without haematoma evacuation plus best medical treatment (BMT) in people with ICH decreases the risk of death or dependence at 6 months compared to BMT alone. Methods and design: SWITCH is an international, multicentre, randomised (1:1), two-arm, open-label, assessor-blinded trial. Key inclusion criteria are age ⩽75 years, stroke due to basal ganglia or thalamic ICH that may extend into cerebral lobes, ventricles or subarachnoid space, Glasgow coma scale of 8–13, NIHSS score of 10–30 and ICH volume of 30–100 mL. Randomisation must be performed <66 h after onset and DC <6 h after randomisation. Both groups will receive BMT. Participants randomised to the treatment group will receive DC of at least 12 cm in diameter according to institutional standards. Sample size: A sample of 300 participants randomised 1:1 to DC plus BMT versus BMT alone provides over 85% power at a two-sided alpha-level of 0.05 to detect a relative risk reduction of 33% using a chi-squared test. Outcomes: The primary outcome is the composite of death or dependence, defined as modified Rankin scale score 5–6 at 6 months. Secondary outcomes include death, functional status, quality of life and complications at 180 days and 12 months.

Discussion

SWITCH will inform physicians about the outcomes of DC plus BMT in people with spontaneous deep ICH, compared to BMT alone.

Trial registration

ClinicalTrials.gov Identifier: NCT02258919

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Cerebral HemorrhageDecompressive CraniectomyAdultAgedFemaleHumansMaleMiddle AgedRandomized Controlled Trials as TopicSwitzerlandTreatment OutcomeMulticenter Studies as Topic

Stichwörter der Autor:innen

Intracerebral haemorrhagedecompressive craniectomyrandomised-controlled trial

Autor:innen und Institutionen

  • Department of Neurology, University Hospital and University of Bern, Bern, Switzerland.
  • Department of Neurology, University Hospital and University of Basel, Basel, Switzerland.
  • Department of Neurosurgery, University Hospital and University of Bern, Bern, Switzerland.
  • Department of Neurosurgery, Medical Center University of Freiburg, Freiburg, Germany.
  • CTU Bern, Department of Clinical Research, University of Bern, Bern, Switzerland.
  • Department of Neurosurgery, University Medical Center Mainz, Germany.

ORCID-Profile: Urs Fischer, Werner Z'Graggen, Daniel Strbian, Rustam Al-Shahi Salman, Jenny Bressan, Heinrich P Mattle

Förderung

  • Schweizerischer Nationalfonds zur Förderung der Wissenschaftlichen Forschung
  • Boehringer Ingelheim
  • the Inselspital Stiftung
  • Schweizerische Herzstiftung

Zitieren

APA

Fischer, U., Fung, C., Beyeler, S., Bütikofer, L., Z'Graggen, W., Ringel, F., Gralla, J., Schaller, K., Plesnila, N., Strbian, D., Arnold, M., Hacke, W., Jüni, P., Mendelow, A. D., Stapf, C., Al-Shahi Salman, R., Bressan, J., Lerch, S., Bassetti, C. L. A., …, & Beck, J. (2024). Swiss trial of decompressive craniectomy versus best medical treatment of spontaneous supratentorial intracerebral haemorrhage (SWITCH): an international, multicentre, randomised-controlled, two-arm, assessor-blinded trial. European Stroke Journal. https://doi.org/10.1177/23969873241231047

Vancouver

Fischer U, Fung C, Beyeler S, Bütikofer L, Z'Graggen W, Ringel F, et al. Swiss trial of decompressive craniectomy versus best medical treatment of spontaneous supratentorial intracerebral haemorrhage (SWITCH): an international, multicentre, randomised-controlled, two-arm, assessor-blinded trial. European Stroke Journal. 2024. doi:10.1177/23969873241231047

BibTeX
@article{Fischer2024,
  author = {Fischer, Urs and Fung, Christian and Beyeler, Seraina and Bütikofer, Lukas and Z'Graggen, Werner and Ringel, Florian and Gralla, Jan and Schaller, Karl and Plesnila, Nikolaus and Strbian, Daniel and Arnold, Marcel and Hacke, Werner and Jüni, Peter and Mendelow, Alexander David and Stapf, Christian and Al-Shahi Salman, Rustam and Bressan, Jenny and Lerch, Stefanie and Bassetti, Claudio L A and Mattle, Heinrich P and Raabe, Andreas and Beck, Jürgen},
  title = {Swiss trial of decompressive craniectomy versus best medical treatment of spontaneous supratentorial intracerebral haemorrhage (SWITCH): an international, multicentre, randomised-controlled, two-arm, assessor-blinded trial},
  journal = {European Stroke Journal},
  year = {2024},
  doi = {10.1177/23969873241231047}
}
Kostenlos starten →